Keyphrases
Cardiovascular Risk
100%
Heart Failure with Preserved Ejection Fraction (HFpEF)
100%
Leukocyte Count
100%
TOPCAT
100%
Heart Failure Hospitalization
57%
Nonfatal Myocardial Infarction
42%
Preserved EF
42%
Heart Failure
28%
Cardiovascular Mortality
28%
Confidence Interval
28%
Myeloid Immune Cells
28%
Hazard Ratio
28%
Aborted Cardiac Arrest
28%
Cardiovascular Disease
14%
Cardiac Function
14%
Leukocytes
14%
Clinical Outcomes
14%
Sensitivity Analysis
14%
All-cause Mortality
14%
Prognostic Implications
14%
Confounding
14%
Cell Expansion
14%
Potential Confounders
14%
Platelet Count
14%
Non-cardiovascular Mortality
14%
75th Percentile
14%
In-hospital Outcomes
14%
Combined Influence
14%
Adverse Clinical Outcomes
14%
Total Leukocyte Count
14%
Aldosterone Antagonists
14%
Prognostic Importance
14%
Cardiovascular Hospitalizations
14%
Survival Model
14%
Count Outcomes
14%
Lymphoid Immune Cells
14%
Medicine and Dentistry
Leukocyte
100%
Cardiovascular Risk
100%
Heart Failure with Preserved Ejection Fraction
100%
Congestive Heart Failure
66%
Myocardial Infarction
33%
Cardiovascular Mortality
33%
Hazard Ratio
22%
Heart Arrest
22%
Immunocompetent Cell
22%
Cardiovascular Disease
11%
Platelet
11%
Heart Function
11%
All Cause Mortality
11%
Apoplexy
11%
Cell Expansion
11%
Heart Failure with Reduced Ejection Fraction
11%
Aldosterone Antagonist
11%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure with Preserved Ejection Fraction
100%
Congestive Heart Failure
100%
Cardiovascular Risk
100%
Heart Infarction
50%
Cardiovascular Mortality
50%
Heart Arrest
33%
Aldosterone Antagonist
16%
Heart Failure with Reduced Ejection Fraction
16%
All Cause Mortality
16%
Cerebrovascular Accident
16%
Cardiovascular Disease
16%
Immunology and Microbiology
Heart Ejection Fraction
100%
Leukocyte Count
100%
Cardiovascular Mortality
37%
Immunocompetent Cell
25%
Myeloid
25%
Heart Function
12%
Leukocyte
12%
Cell Expansion
12%
Platelet Count
12%
All Cause Mortality
12%